PFF Summit 2013 Patient/Caregiver Sessions
Patient and Caregiver Sessions
Friday > Sessions
Welcome and Introduction, Daniel M. Rose, MD, CEO and Chairman of the Board, Pulmonary Fibrosis Foundation VIEW SLIDES
Opening Session Keynote Address, Cystic Fibrosis Therapeutic Development: A Game Changer, Robert J. Beall,
What is Pulmonary Fibrosis (PF), What are the Causes, and How is it Treated?, Harold R. Collard, MD VIEW SLIDES
What is Autoimmune Related Pulmonary Fibrosis?, Richard T. Meehan, MD VIEW SLIDES
What is Pulmonary Hypertension and How is it Related to PF?, Steven Kawut, MD, MS
Special Luncheon Speaker: When Drug Research is Personal: The Importance of Patient Advocacy in Drug Development and Innovation, John F. Crowley, JD, MBA, Chairman and CEO, Amicus Therapeutics | VIEW SLIDES
Occupational and Environmental Related Pulmonary Fibrosis, Cecile S. Rose, MD, MPH
Saturday > Sessions
Research Trials, Stem Cell Therapies, and the Drug Pipeline, Erica L. Herzog, MD VIEW SLIDES
Lung Transplantation and PF, Errol L. Bush, MD VIEW SLIDES
The Final Stages of Pulmonary Disease, Molly Bourne, MD
Tools for Living Better with Pulmonary Fibrosis, Susan S. Jacobs, RN, MS VIEW SLIDES
Effective Advocacy for Pulmonary Fibrosis, Brian Baird, MS,
The Role of the FDA in the Process of Drug Development, Eugene J. Sullivan, MD VIEW SLIDES
US Food and Drug Administration -- Patient-Focused Drug Development Program, Richard M. Klein
Meet the Experts–Q+A Roundtable Discussions


